Cited 0 times in Scipus Cited Count

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy

DC Field Value Language
dc.contributor.authorKwon, DH-
dc.contributor.authorHwang, JS-
dc.contributor.authorKim, SG-
dc.contributor.authorJang, YE-
dc.contributor.authorShin, TH-
dc.contributor.authorLee, G-
dc.date.accessioned2023-02-21T04:33:49Z-
dc.date.available2023-02-21T04:33:49Z-
dc.date.issued2022-
dc.identifier.issn1661-6596-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24722-
dc.description.abstractParkinson's disease (PD) and multiple system atrophy (MSA) belong to the neurodegenerative group of synucleinopathies; differential diagnosis between PD and MSA is difficult, especially at early stages, owing to their clinical and biological similarities. Thus, there is a pressing need to identify metabolic biomarkers for these diseases. The metabolic profile of the cerebrospinal fluid (CSF) is reported to be altered in PD and MSA; however, the altered metabolites remain unclear. We created a single network with altered metabolites in PD and MSA based on the literature and assessed biological functions, including metabolic disorders of the nervous system, inflammation, concentration of ATP, and neurological disorder, through bioinformatics methods. Our in-silico prediction-based metabolic networks are consistent with Parkinsonism events. Although metabolomics approaches provide a more quantitative understanding of biochemical events underlying the symptoms of PD and MSA, limitations persist in covering molecules related to neurodegenerative disease pathways. Thus, omics data, such as proteomics and microRNA, help understand the altered metabolomes mechanism. In particular, integrated omics and machine learning approaches will be helpful to elucidate the pathological mechanisms of PD and MSA. This review discusses the altered metabolites between PD and MSA in the CSF and omics approaches to discover diagnostic biomarkers.-
dc.language.isoen-
dc.subject.MESHBiomarkers-
dc.subject.MESHComputational Biology-
dc.subject.MESHEarly Diagnosis-
dc.subject.MESHHumans-
dc.subject.MESHMachine Learning-
dc.subject.MESHMetabolomics-
dc.subject.MESHMultiple System Atrophy-
dc.subject.MESHParkinson Disease-
dc.titleCerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy-
dc.typeArticle-
dc.identifier.pmid35163800-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836409-
dc.subject.keywordCerebrospinal fluid-
dc.subject.keywordIntegrated omics-
dc.subject.keywordMachine learning-
dc.subject.keywordMetabolomics-
dc.subject.keywordMultiple system atrophy-
dc.subject.keywordParkinson’s disease-
dc.contributor.affiliatedAuthorShin, TH-
dc.contributor.affiliatedAuthorLee, G-
dc.type.localJournal Papers-
dc.identifier.doi10.3390/ijms23031879-
dc.citation.titleInternational journal of molecular sciences-
dc.citation.volume23-
dc.citation.number3-
dc.citation.date2022-
dc.citation.startPage1879-
dc.citation.endPage1879-
dc.identifier.bibliographicCitationInternational journal of molecular sciences, 23(3). : 1879-1879, 2022-
dc.identifier.eissn1422-0067-
dc.relation.journalidJ014220067-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Files in This Item:
35163800.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse